eMedicine Specialties > Pediatrics: Developmental and Behavioral > Medical Topics
Mood Disorder: Depression
Updated: Mar 3, 2008
Introduction
Background
Childhood and adolescent major depressive disorder (MDD) is a prevalent, familial, and recurrent condition that generally continues episodically into adulthood. Childhood depression seems to be evident at earlier ages in successive cohorts and often occurs with comorbid psychiatric disorders, increased risk for suicide, substance abuse, and behavior problems. Children and adolescents with depression frequently have poor psychosocial, academic, and family functioning.
Pathophysiology
Several areas of the brain are involved in mood functions. Sleep, appetite, and memory are commonly disturbed in persons with depression. Except for the pituitary, all cerebral components responsible for these functions are broadly considered to be a part of the limbic system; all components normally receive signals from neurons that secrete serotonin or norepinephrine or from neurons of both types. Reductions in the activity of circuits that use serotonin and norepinephrine are thought to contribute to depression.
Frequency
United States
Reported prevalence rates for depression in children and adolescents vary. Differences may be due to different populations sampled and variable criteria used.
In 1988, Kashani and Sherman conducted epidemiologic studies in the United States that revealed the incidence of depression to be 0.9% in preschool-aged children, 1.9% in school-aged children, and 4.7% in adolescents.1 A study of a randomly selected sample of high school students revealed that 22.3% of females and 11.4% of male high school students reported one current or lifetime episode of unipolar depression. The percentage of male and female students with 2 or more episodes was 4.9% and 1.6%, respectively. In 1997, Garrison et al conducted a study of adolescents aged 11-16 years in the southeastern United States and found that the 1-year incidence of major depression was 3.3%.2
As these studies demonstrate, the occurrence of depression is not rare and is encountered regularly in pediatric and psychiatric practice.
International
Available data on the international incidence of major depression in children and adolescents are sparse. Reported adult prevalence rates generally mirror those of the United States.
Helgason examined the entire Icelandic birth cohort of 1895-97 with periodic follow-up until cohort individuals reached age 74-76 years. The lifetime estimates of risk for any affective disorder were 14.8% for females and 9.8% for males.
The Stirling County Study, which began shortly after World War II, offers a 40-year perspective of the prevalence and incidence of psychiatric disorders among an adult population in Atlantic, Canada. In 2000, Murphy et al found the overall prevalence of depression remained stable at 5% across 3 separate samples in 1952, 1970, and 1992.3 They reported a redistribution in the most recent sample that indicated prevalence had shifted from older to younger persons and that the female-to-male ratio had increased.
In 1999, a European study by Copeland et al sought to assess the prevalence of depression in 9 European nations in order to design intervention for elderly persons who were depressed.4 They found widely ranging prevalences in their study centers. Prevalence for females was higher than for males. They found no constant association between prevalence and age. Meta-analysis revealed an overall prevalence of 12.3% and sex frequencies of 14.1% for females and 8.6% for males.
According to Jablensky in 1981, the World Health Organization (WHO) collaborative study on the assessment of depressive disorders examined depressive patients in Canada, Iran, Japan, and Switzerland and found considerable similarity in depressive symptomatology across cultures.5
Mortality/Morbidity
As many as 15% of those with depression or bipolar disorder commit suicide each year. In 1996, the Centers for Disease Control and Prevention (CDC) listed suicide as the ninth leading cause of death in the United States, accounting for 30,862 deaths. Many believe this number is a gross underestimate. For example, children's deaths are often ruled as accidental when the intent of the deceased is not apparent. The feasibility of suicide among children is frequently unthinkable, even to health professionals. Because mood disorders, such as depression, substantially increase the risk of suicide, suicidal behavior is a matter of serious concern for clinicians who deal with the mental health problems of children and adolescents. The incidence of suicide attempts reaches a peak during the mid adolescent years; the mortality rate from suicide increases steadily through the teenage years; suicide is the third leading cause of death in that age group.
Risk factors for completed suicide include the presence of a major mood disorder, occurrence of command auditory hallucinations, use of substances, and evidence of specific plans and an attempt to prevent discovery. Major depression with psychotic features, such as hallucinations, places an individual at increased risk of harm to themselves or others. Psychosis and risk of harm to self or others are indications for hospitalization.
Race
Cultural norms associated with differing racial and ethnic groups can affect the experience and reporting of symptoms of depression. For example, in some cultures, depression may be experienced largely in somatic terms, in place of sadness or guilt. Several studies point toward the role of culture in childhood and adolescent depression. For example, the stress of acculturation was found to have a role in the increased incidence of depressive symptoms and suicidal ideation among Hispanic youths.
In an epidemiologic study of youths aged 12-17 years in Los Angeles County in 1998, Siegel et al found that Hispanic youths reported more symptoms of depression, independent of socioeconomic status, when compared with white, African American, or Asian American adolescents, using the Children's Depression Inventory (CDI).6 This study also found significant effects of social class on depression. As income decreased, the average level of depression increased.
More extensive studies of ethnic subpopulations of adolescents who are depressed are needed. The Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) states that a symptom should not be dismissed because it is part of a cultural norm.7 Likewise, culturally distinctive experiences (eg, fear of being hexed or bewitched; experience of visitations from the dead) should be distinguished from actual hallucinations or delusions that may be part of a major depressive episode with psychotic features.
Sex
Sex issues and depression in youths has been the subject of much research. In 1998, Hankin et al conducted a prospective, 10-year, longitudinal study of preadolescents through young adulthood and found that the most critical time for sex differences to emerge is the period when adolescents are aged 15-18 years.8 During this period, the increase of the overall rates of depression and onset of new cases of depression peak. The rates of depression increase dramatically for both sexes, and the rate of depression in females grows to twice the prevalence rate for males. No sex differences are noted for depression symptom severity or recurrence.
Age
Evidence suggests that the presentation of some symptoms may change with age. Symptoms, such as somatic complaints, irritability, and social withdrawal, are more common in children, whereas psychomotor retardation, hypersomnia, and delusions are less common prior to puberty than in adolescence and adulthood.
Clinical
History
The Diagnostic and Statistical Manual of Mental Disorders, Third Edition (DSM-III); the Diagnostic and Statistical Manual of Mental Disorders, Third Edition Revised (DSM-III-R); and the DSM-IV use the same basic criteria to diagnose depression in adults and children. A few small adjustments were made to the diagnostic criteria to account for the differences in age and stage of development in adults and children.
The DSM-IV diagnostic criteria for depressive disorders are the same for children and adolescents as they are for adults, with small exceptions stated as notations to the criteria.
- The DSM-IV defines a major depressive episode as a syndrome in which at least 5 of the following symptoms have been present during the same 2-week period:
- Depressed mood (for children and adolescents, this also can be an irritable mood)
- Diminished interest or loss of pleasure in almost all activities
- Sleep disturbance
- Weight change or appetite disturbance (for children this can be failure to achieve expected weight gain)
- Decreased concentration or indecisiveness
- Suicidal ideation or thoughts of death
- Psychomotor agitation or retardation
- Fatigue or loss of energy
- Feelings of worthlessness or inappropriate guilt
- At least one of the symptoms must be diminished interest/pleasure or depressed mood. The symptoms must cause significant distress or impairment of functioning in social, occupational, or other important areas. Depression should not have been precipitated by the direct action of a substance or the result of a medical condition and should not be better explained by bereavement or schizoaffective disorder. Additionally, a major depressive episode should not be superimposed on schizophrenia, schizophreniform disorder, delusional disorder, or a psychotic disorder not otherwise specified.
- Depressive disorders can be rated as mild, moderate, or severe. The disorder can also occur with or without psychotic symptoms, which can be mood congruent or incongruent. Depressive disorders can be determined to be in full or partial remission. When an episode lasts more than 2 consecutive years, the depression should be diagnosed as chronic. Depression may also have melancholic features. Either a loss of pleasure in almost all activities or a lack of reactivity to usually pleasurable stimuli are present. Additionally, at least 3 of the following are required:
- A depressed mood that is distinctly different from the kind felt when a loved one is deceased
- Depression that is worse in the morning
- Waking up 2 hours earlier than usual
- Observable psychomotor retardation or agitation
- Significant weight loss or anorexia
- Excessive or inappropriate guilt
- Depressive episodes can also be present with catatonic features that require at least 2 of the following, as illustrated in the DSM-IV:
- Motoric immobility in the form of catalepsy or stupor
- Motor overactivity that seems purposeless and not in response to external stimuli
- Extreme negativism or mutism
- Voluntary movement peculiarities such a posturing, grimacing, stereotypy, and mannerisms
- Echolalia or echopraxia
- The seasonality of a depressive disorder can also be specified. To diagnose a seasonal mood disorder, a regular temporal relationship should exist between the depression and a particular time of year. An individual should demonstrate at least 2 episodes of depressive disturbance in the prior 2 years, and seasonal episodes should substantially outnumber nonseasonal episodes. Diagnosing seasonal affective disorder in children is difficult because they experience the recurrent universal stressor of beginning school every autumn. Also, a young child might present with an apparent seasonal depressive disorder but not yet have had prior episodes.
- A depression may also be identified as having atypical features. Characteristics of this subtype are mood reactivity and exclusion of melancholic and catatonic subtypes in addition to 2 or more of the following for the a period of at least 2 weeks:
- Increase in appetite or significant weight gain
- Increased sleep
- Feelings of heaviness in arms or legs
- A pattern of long-standing interpersonal rejection sensitivity that extends far beyond the mood disturbance episodes and results in significant impairment in social or occupational functioning
- The DSM-IV also includes a category for depressive disorders not otherwise specified. This category includes disorders with features of depression that do not meet criteria for a specific mood disorder or adjustment disorder with depressed mood. Examples include a depressive episode superimposed on residual schizophrenia, a recurrent mild depressive disturbance that does not meet criteria for dysthymia, or non–stress-related episodes that do not meet the criteria for a major depressive episode. Consult the DSM-IV for further details as to the diagnostic criteria for depressive disorders not otherwise specified.
Physical
- A complete mental health evaluation should always include a medical evaluation.
- Organic etiologies that might imitate a depressive disorder must be ruled out.
- Conditions believed to mimic depressive disorders fall into the major general categories, including the following:
- Infection
- Medication
- Endocrine disorder
- Tumor
- Neurologic disorder
- Miscellaneous disorder
Causes
Whether ego-damaging experiences or biological processes cause depression remains the topic of some debate. The final common pathways to depression involve biochemical changes in the brain.
- Neuroimaging
- A recently discovered abnormality in an area of the brain that helps to control emotional reactions contributes to a new understanding of why persons develop depression and other affective disturbances. By using positron emission tomographic (PET) images, researchers found an area of the prefrontal cortex with an abnormally diminished activity in patients with unipolar depression and bipolar depression. This region is related to emotional response and has widespread connections with other areas of the brain. These other areas are responsible for the regulation of dopamine, noradrenaline, and serotonin, which have important roles in the regulation of mood. PET imaging provides the means for the study of receptor volume and the effect a compound may have on receptors; however, PET is problematic for use with children and adolescents because it requires complex equipment and uses radiation.
- MRI, magnetic resonance spectroscopy (MRS), and magnetoencephalography (MEG) are best suited to study the structural, physiological, and developmental brain abnormalities in youths because they do not involve ionizing radiation or radioactive isotopes. To date, few neuroimaging studies have been performed in depressed youths. In 1996, Steingard et al observed 65 latency-aged children and adolescents who were hospitalized with depression.9 MRI was used to compare depressed patients with 18 hospitalized psychiatric controls who did not have a depressive disorder. Depressed youths had a significantly smaller ratio of frontal lobe volume to total cerebral volume and a significantly larger ratio of lateral ventricular volume to total cerebral volume than controls. The researchers in this study suggest that these alterations in cerebral volumes may suggest a role for the frontal lobes in the development of early-onset depression.
- In 1998, Tutus et al observed adolescents with MDD using single-photon emission tomography (SPET) in order to examine cerebral perfusion and any association between perfusion indices and clinical variables.10 Fourteen adolescent outpatients (aged 11-15 y) with MDD and 11 age-matched controls were studied. Significant differences were found between the perfusion index values of untreated depressed patients and those of the controls. The findings were indicative of relatively reduced perfusion in the left anterofrontal and left temporal cortical areas. They suggest that adolescents with MDD may have regional blood flow deficits in left anterofrontal and left temporal cortical regions with greater right-left perfusion asymmetry compared with healthy controls.
- Neuroendocrine abnormalities
- In 1996, De Bellis et al studied neuroendocrine changes in prepubertal children who were depressed.11 They examined nocturnal secretion of adrenocorticotropin (ACTH), cortisol, growth hormone (GH), and prolactin in the depressed groups and control groups, respectively. Prepubertal children who were depressed had lower cortisol secretion during the first 4 hours of sleep than did children in the control group. ACTH, GH, and prolactin secretion did not differ between the 2 groups.
- Possible abnormalities of the neurotransmitter systems remain under investigation. In 1999, Nobile et al found that human platelet 5-HT (serotonin) uptake is differentially influenced in nondepressed and depressed children by a common genetic variant of the promotor region of 5-HTT.12 In 1997, Birmaher et al found that, prior to onset of affective illness, children who were at high risk had the same pattern of neuroendocrine response to 5-hydroxy-L-tryptophan (L-5-HTP) challenge as did children with major depression.13 These findings could constitute the identification of a trait marker for depression in children.
- Genetic studies: Several studies of adults who are depressed, such as those reported by Akiskal and Weller in 198914 and Weissman et al in 1984,15 suggest a genetic component in the etiology of depressive disorders.
- Parent-child relation model
- This model conceptualizes depression as the result of poor parent-child interaction. Adults with depression report low paternal involvement and high maternal overprotection during early childhood. Troubled relationships with parents, siblings, and peers are common in children and adolescents with affective illness. A child who is affectively ill often has a parent who is affectively ill. For children to report abuse and/or neglect by their parent(s) who is affectively ill is not uncommon.
- In 1991, Hammen et al reported a significant temporal association between mother and child.16 They found that children with substantial stress exposure who also had symptomatic mothers were significantly more depressed than children who were exposed to comparable levels of stress only.
- Cohort effect: In 1987, Klerman and Gershon reported a progressive increase in the lifetime cases of major depression over the last 70 years. They found high rates of affective disorders among relatives, with a younger age of onset in successive cohorts.
More on Mood Disorder: Depression |
Overview: Mood Disorder: Depression |
| Differential Diagnoses & Workup: Mood Disorder: Depression |
| Treatment & Medication: Mood Disorder: Depression |
| Follow-up: Mood Disorder: Depression |
| References |
| Next Page » |
References
Kashani JH, Sherman DD. Childhood depression: Epidemiology, etiological models, and treatment implications. Integr Psychiatry. 1988;6:1-8.
Garrison CZ, Waller JL, Cuffe SP, et al. Incidence of major depressive disorder and dysthymia in young adolescents. J Am Acad Child Adolesc Psychiatry. Apr 1997;36(4):458-65. [Medline].
Murphy JM, Laird NM, Monson RR, et al. Incidence of depression in the Stirling County Study: historical and comparative perspectives. Psychol Med. May 2000;30(3):505-14. [Medline].
Copeland JR, Beekman AT, Dewey ME, et al. Depression in Europe. Geographical distribution among older people. Br J Psychiatry. Apr 1999;174:312-21. [Medline].
Jablensky A, Sartorius N, Gulbinat W, Ernberg G. Characteristics of depressive patients contacting psychiatric services in four cultures. A report from the who collaborative study on the assessment of depressive disorders. Acta Psychiatr Scand. Apr 1981;63(4):367-83. [Medline].
Siegel JM, Aneshensel CS, Taub B. Adolescent depressed mood in a multiethnic sample. J Youth Adolesc. 1998;27.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM- IV). 4th ed. Washington, DC: American Psychiatric Association; 1994.
Hankin BL, Abramson LY, Moffitt TE, et al. Development of depression from preadolescence to young adulthood: emerging gender differences in a 10-year longitudinal study. J Abnorm Psychol. Feb 1998;107(1):128-40. [Medline].
Steingard RJ, Renshaw PF, Yurgelun-Todd D, et al. Structural abnormalities in brain magnetic resonance images of depressed children. J Am Acad Child Adolesc Psychiatry. Mar 1996;35(3):307-11. [Medline].
Tutus A, Kibar M, Sofuoglu S, et al. A technetium-99m hexamethylpropylene amine oxime brain single-photon emission tomography study in adolescent patients with major depressive disorder. Eur J Nucl Med. Jun 1998;25(6):601-6. [Medline].
De Bellis MD, Dahl RE, Perel JM, et al. Nocturnal ACTH, cortisol, growth hormone, and prolactin secretion in prepubertal depression. J Am Acad Child Adolesc Psychiatry. Sep 1996;35(9):1130-8. [Medline].
Nobile M, Begni B, Giorda R, et al. Effects of serotonin transporter promoter genotype on platelet serotonin transporter functionality in depressed children and adolescents. J Am Acad Child Adolesc Psychiatry. Nov 1999;38(11):1396-402. [Medline].
Birmaher B, Kaufman J, Brent DA, et al. Neuroendocrine response to 5-hydroxy-L-tryptophan in prepubertal children at high risk of major depressive disorder. Arch Gen Psychiatry. Dec 1997;54(12):1113-9. [Medline].
Akiskal HS, Weller ES. Mood disorders and suicide in children and adolescents. In: Kaplan HI, Saddock BJ, eds. Comprehensive Textbook of Psychiatry. Vol 2. 5th ed. Lippincott Williams & Wilkins; 1989.
Weissman MM, Leckman JF, Merikangas KR, et al. Depression and anxiety disorders in parents and children. Results from the Yale family study. Arch Gen Psychiatry. Sep 1984;41(9):845-52. [Medline].
Hammen C, Burge D, Adrian C. Timing of mother and child depression in a longitudinal study of children at risk. J Consult Clin Psychol. Apr 1991;59(2):341-5. [Medline].
Weller EB, Weller RA, Fristad MA, et al. The dexamethasone suppression test in prepubertal depressed children. J Clin Psychiatry. Dec 1985;46(12):511-3. [Medline].
Mufson L, Fairbanks J. Interpersonal psychotherapy for depressed adolescents: a one-year naturalistic follow-up study. J Am Acad Child Adolesc Psychiatry. Sep 1996;35(9):1145-55. [Medline].
Kroll L, Harrington R, Jayson D, et al. Pilot study of continuation cognitive-behavioral therapy for major depression in adolescent psychiatric patients. J Am Acad Child Adolesc Psychiatry. Sep 1996;35(9):1156-61. [Medline].
Brent DA, Kolko DJ, Birmaher B, et al. Predictors of treatment efficacy in a clinical trial of three psychosocial treatments for adolescent depression. J Am Acad Child Adolesc Psychiatry. Sep 1998;37(9):906-14. [Medline].
Leonard HL, March J, Rickler KC, Allen AJ. Pharmacology of the selective serotonin reuptake inhibitors in children and adolescents. J Am Acad Child Adolesc Psychiatry. Jun 1997;36(6):725-36. [Medline].
Rey-Sanchez F, Gutierrez-Casares JR. Paroxetine in children with major depressive disorder: an open trial. J Am Acad Child Adolesc Psychiatry. Oct 1997;36(10):1443-7. [Medline].
Emslie GJ, Rush AJ, Weinberg WA, et al. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression. Arch Gen Psychiatry. Nov 1997;54(11):1031-7. [Medline].
King RA, Segman RH, Anderson GM. Serotonin and suicidality: the impact of acute fluoxetine administration. I: Serotonin and suicide. Isr J Psychiatry Relat Sci. 1994;31(4):271-9. [Medline].
Teicher MH, Glod CA, Cole JO. Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf. Mar 1993;8(3):186-212. [Medline].
Carlsten A, Waern M, Ekedahl A, Ranstam J. Antidepressant medication and suicide in Sweden. Pharmacoepidemiol Drug Saf. Oct-Nov 2001;10(6):525-30. [Medline].
Hall WD, Mant A, Mitchell PB, et al. Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis. BMJ. May 10 2003;326(7397):1008. [Medline]. [Full Text].
Olfson M, Marcus SC, Druss B, Pincus HA. National trends in the use of outpatient psychotherapy. Am J Psychiatry. Nov 2002;159(11):1914-20. [Medline]. [Full Text].
March J, Silva S, Petrycki S, et al. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA. Aug 18 2004;292(7):807-20. [Medline].
Simon GE, Savarino J, Operskalski B, Wang PS. Suicide risk during antidepressant treatment. Am J Psychiatry. Jan 2006;163(1):41-7. [Medline]. [Full Text].
Department of Health and Human Services, US Food and Drug Administration, Center for Drug Evaluation and Research. Antidepressant Use in Children, Adolescents, and Adults: Labeling Template. www.fda.gov/cder/drug/antidepressants/PI_template.pdf. Available at http://www.fda.gov/cder/drug/antidepressants/PI_template.pdf.. Accessed February 28,2005.
AACAP. Practice parameters for the assessment and treatment of children and adolescents with depressive disorders. AACAP. J Am Acad Child Adolesc Psychiatry. Oct 1998;37(10 Suppl):63S-83S. [Medline].
Pine DS, Cohen E, Cohen P, Brook J. Adolescent depressive symptoms as predictors of adult depression: moodiness or mood disorder?. Am J Psychiatry. Jan 1999;156(1):133-5. [Medline]. [Full Text].
Ambrosini PJ, Wagner KD, Biederman J, et al. Multicenter open-label sertraline study in adolescent outpatients with major depression. J Am Acad Child Adolesc Psychiatry. May 1999;38(5):566-72. [Medline].
Birmaher B, Brent DA, Kolko D, et al. Clinical outcome after short-term psychotherapy for adolescents with major depressive disorder. Arch Gen Psychiatry. Jan 2000;57(1):29-36. [Medline].
Birmaher B, Ryan ND, Williamson DE, et al. Childhood and adolescent depression: a review of the past 10 years. Part I. J Am Acad Child Adolesc Psychiatry. Nov 1996;35(11):1427-39. [Medline].
Birmaher B, Ryan ND, Williamson DE, et al. Childhood and adolescent depression: a review of the past 10 years. Part II. J Am Acad Child Adolesc Psychiatry. Dec 1996;35(12):1575-83. [Medline].
Clarke GN, Rohde P, Lewinsohn PM, et al. Cognitive-behavioral treatment of adolescent depression: efficacy of acute group treatment and booster sessions. J Am Acad Child Adolesc Psychiatry. Mar 1999;38(3):272-9. [Medline].
Daly JM, Wilens T. The use of tricyclic antidepressants in children and adolescents. Pediatr Clin North Am. Oct 1998;45(5):1123-35. [Medline].
Drevets WC, Price JL, Simpson JR, et al. Subgenual prefrontal cortex abnormalities in mood disorders. Nature. Apr 24 1997;386(6627):824-7. [Medline].
Geller B, Reising D, Leonard HL, et al. Critical review of tricyclic antidepressant use in children and adolescents. J Am Acad Child Adolesc Psychiatry. May 1999;38(5):513-6. [Medline].
Hamilton J, Gillham J. The K-SADS and diagnosis of major depressive disorder. J Am Acad Child Adolesc Psychiatry. Sep 1999;38(9):1065-9. [Medline].
Hazell P, O'Connell D, Heathcote D, Robertson J, Henry D. Efficacy of tricyclic drugs in treating child and adolescent depression: a meta-analysis. BMJ. Apr 8 1995;310(6984):897-901. [Medline].
Hendren RL, De Backer I, Pandina GJ. Review of neuroimaging studies of child and adolescent psychiatric disorders from the past 10 years. J Am Acad Child Adolesc Psychiatry. Jul 2000;39(7):815-28. [Medline].
Hovey JD, King CA. Acculturative stress, depression, and suicidal ideation among immigrant and second-generation Latino adolescents. J Am Acad Child Adolesc Psychiatry. Sep 1996;35(9):1183-92. [Medline].
Kovacs M, Gatsonis C. Secular trends in age at onset of major depressive disorder in a clinical sample of children. J Psychiatr Res. May-Jun 1994;28(3):319-29. [Medline].
Kurian BT, Ray WA, Arbogast PG, et al. Effect of regulatory warnings on antidepressant prescribing for children and adolescents. Arch Pediatr Adolesc Med. Jul 2007;161(7):690-6. [Medline].
Lewinsohn PM, Clarke GN, Seeley JR, Rhode P. Major depression in community adolescents: age at onset, episode duration, and time to recurrence. J Am Acad Child Adolesc Psychiatry. Jul-Aug 1994;33(6):809-18. [Medline].
Lewinsohn PM, Hops H, Roberts RE, et al. Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. J Abnorm Psychol. Feb 1993;102(1):133-44. [Medline].
Lewinsohn PM, Rohde P, Klein DN, Seeley JR. Natural course of adolescent major depressive disorder: I. Continuity into young adulthood. J Am Acad Child Adolesc Psychiatry. Jan 1999;38(1):56-63. [Medline].
Newman TB. A black-box warning for antidepressants in children?. N Engl J Med. Oct 14 2004;351(16):1595-8. [Medline].
Schulterbrandt JG, Raskin A. Depression in Childhood: Diagnosis, Treatment and Conceptual Models. New York, NY: Raven Press; 1977.
Strober M, DeAntonio M, Schmidt-Lackner S, et al. The pharmacotherapy of depressive illness in adolescents: an open-label comparison of fluoxetine with imipramine-treated historical controls. J Clin Psychiatry. Mar 1999;60(3):164-9. [Medline].
Taketomo CK, Hodding JH, Kraus DM. Pediatric Dosage Handbook. 7th ed. Hudson, Ohio: Lexi-Comp, Inc; 2000.
Wagner KD, Ambrosini P, Rynn M, et al. Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials. JAMA. Aug 27 2003;290(8):1033-41. [Medline].
Weller EB, Weller RA. Clinical aspects of childhood depression. Pediatr Ann. Dec 1986;15(12):843-7. [Medline].
Wickramaratne PJ, Greenwald S, Weissman MM. Psychiatric disorders in the relatives of probands with prepubertal- onset or adolescent-onset major depression. J Am Acad Child Adolesc Psychiatry. Nov 2000;39(11):1396-405. [Medline].
Further Reading
Keywords
major depressive disorder, MDD, manic-depressive disorder, bipolar disorder, suicide, suicidal ideation, childhood depression, serotonin, auditory hallucinations, depressed mood, sleep disturbance, catalepsy, seasonal mood disorder, seasonal affective disorder, attention deficit hyperactivity disorder, ADHD, anxiety, posttraumatic stress disorder
Overview: Mood Disorder: Depression